To investigate the single escalating dose of TAK-480

• Research type

  Research Study

• Full title

  A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Sequential-Panel, Ascending Single-Dose Study of TAK-480 to Evaluate the Safety, Tolerability,Pharmacokinetics, and Effect of Food in Healthy Subjects

• IRAS ID

  31643

• Sponsor organisation

  Takeda Global Research & Development Centre (Europe) Ltd.

• Eudract number

  2009-014411-12

• Research summary

  Research Summary not published at request of researcher

• REC name

  London - London Bridge Research Ethics Committee

• REC reference

  09/H0804/79

• Date of REC Opinion

  8 Oct 2009

• REC opinion

  Further Information Favourable Opinion